Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Opin Chem Biol. 2004 Jun;8(3):334-8.

Complex phenotypic assays in high-throughput screening.

Author information

1
Initiative for Chemical Genetics, ICCB-Broad Institute, Harvard University, 320 Charles Street, Room 184, Cambridge, Massachusetts 02141, USA. pclemons@hms.harvard.edu

Abstract

High-throughput screening (HTS), systematically testing thousands of small molecules to find candidates for lead optimization, primarily involves exposure of purified proteins to arrayed collections of small molecules. More complex phenotypic assays, such as cell-based or whole-organism assays, traditionally have flanked HTS, preceding it to validate new therapeutic targets, and following it to characterize new lead compounds in cellular contexts. Recently, however, cell- and organism-based phenotypic assays have increasingly been adopted as a primary screening platform for annotating small molecules.

PMID:
15183333
DOI:
10.1016/j.cbpa.2004.04.002
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center